An Interest In:
Web News this Week
- November 3, 2024
- November 2, 2024
- November 1, 2024
- October 31, 2024
- October 30, 2024
- October 29, 2024
- October 28, 2024
April 16, 2020 05:05 pm
Photo by Samir Jana/Hindustan Times via Getty Images
Original Link: https://www.theverge.com/2020/4/16/21221958/coronavirus-treatment-data-hydroxychloroquine-trump-remdesivir
The search for COVID-19 treatments shows how messy science can be
Photo by Samir Jana/Hindustan Times via Getty Images
There’s yet another new study out this week on hydroxychloroquine, the anti-malaria drug championed by President Trump (without evidence) as a cure for COVID-19. Bottom line: the hospitalized patients who took it didn’t seem to be any better off than patients who didn’t take the drug. Some patients had to stop taking the drug because of cardiac side effects.
The report isn’t published yet, and hasn’t gone through the standard review process, but doctors are starting to sort through its findings. It’s not a good sign for the drug. But this single study is not a killer blow, either.
That’s because a lone study or single clinical trial rarely offers incontrovertible evidence to disprove or bolster a claim — especially if, like this one,...
Original Link: https://www.theverge.com/2020/4/16/21221958/coronavirus-treatment-data-hydroxychloroquine-trump-remdesivir
Share this article:
Tweet
View Full Article
The Verge
The Verge is an ambitious multimedia effort founded in 2011More About this Source Visit The Verge